A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

IsraelRecruitingPHASE3

Conditions

Non Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • UAMS Winthrop P. Rockefeller Cancer Institute ( Site 0060), Little Rock, Arkansas, United States

    Study coordinator · 601-278-6499
  • Highlands Oncology Group-Research Department ( Site 0062), Springdale, Arkansas, United States

    Study coordinator · 479-334-2562
  • Beverly Hills Cancer Center ( Site 0070), Beverly Hills, California, United States

    Study coordinator · 310-432-8933
  • The Angeles Clinic and Research Institute ( Site 0040), Los Angeles, California, United States

    Study coordinator · 310-582-7900
  • The Angeles Clinic and Research Institute- A Cedars-Sinai Affiliate ( Site 0079), Los Angeles, California, United States

    Study coordinator · 310-582-7900
  • UCLA Clinical & Translational Research Center (CTRC) ( Site 0033), Los Angeles, California, United States

    Study coordinator · 424-325-9070
  • Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach, California, United States

    Study coordinator · 949-764-4060
  • St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 4002), Orange, California, United States

    Study coordinator · 714-734-6220
  • San Francisco Oncology Associates ( Site 0066), San Francisco, California, United States

    Study coordinator · 415-600-1102
  • Stamford Hospital ( Site 0083), Stamford, Connecticut, United States

    Study coordinator · 203-358-8879
  • Mayo Clinic in Florida ( Site 0014), Jacksonville, Florida, United States

    Study coordinator · 904-953-3570
  • Mount Sinai Cancer Center ( Site 0038), Miami Beach, Florida, United States

    Study coordinator · 305-674-2625
  • Mid Florida Hematology and Oncology Center ( Site 0018), Orange City, Florida, United States

    Study coordinator · 386-960-7070
  • Emory University School of Medicine-Phase I ( Site 0056), Atlanta, Georgia, United States

    Study coordinator · 404-778-1900
  • Northside Hospital ( Site 0055), Atlanta, Georgia, United States

    Study coordinator · 404-851-8000
  • Centricity Research Columbus Cancer Center ( Site 0005), Columbus, Georgia, United States

  • Southeastern Regional Medical Center ( Site 0065), Newnan, Georgia, United States

    Study coordinator · 770-400-6000
  • Lewis Cancer and Research Pavilion ( Site 0063), Savannah, Georgia, United States

    Study coordinator · 912-819-5704
  • Archbold Cancer Center ( Site 0071), Thomasville, Georgia, United States

    Study coordinator · 229-584-5417
  • Edward-Elmhurst Healthcare, Elmhurst Hospital-Nancy W. Knowles Cancer Center ( Site 0017), Elmhurst, Illinois, United States

  • Accellacare of Duly ( Site 4005), Lisle, Illinois, United States

    Study coordinator · 630-545-7760
  • Edward-Elmhurst Healthcare, Edward Hospital-Edward Cancer Center ( Site 0078), Naperville, Illinois, United States

  • Parkview Research Center at Parkview Regional Medical Center ( Site 0089), Fort Wayne, Indiana, United States

    Study coordinator · 260-266-6626
  • Indiana University Health Arnett Cancer Center ( Site 0076), Lafayette, Indiana, United States

    Study coordinator · 765-838-6885
  • Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0061), Edgewood, Kentucky, United States

    Study coordinator · 859-301-4736
  • LSU Health Baton Rouge North Clinic ( Site 4003), Baton Rouge, Louisiana, United States

    Study coordinator · 225-765-7956
  • Our Lady of the Lake Physician Group-Medical Oncology ( Site 0080), Baton Rouge, Louisiana, United States

    Study coordinator · 225-765-7956
  • New England Cancer Specialists ( Site 0095), Westbrook, Maine, United States

    Study coordinator · 207-303-3300
  • Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0027), Minneapolis, Minnesota, United States

    Study coordinator · 888-425-5462
  • Mayo Clinic - Rochester ( Site 0073), Rochester, Minnesota, United States

    Study coordinator · 904-953-1050
  • Mercy South - David M Sindelar Cancer Center ( Site 0098), St Louis, Missouri, United States

    Study coordinator · 314-525-4928
  • Mercy Research - David C. Pratt Cancer Center ( Site 0006), St Louis, Missouri, United States

    Study coordinator · 314-251-4400
  • Renown Regional Medical Center-Renown Health Medical Oncology ( Site 0037), Reno, Nevada, United States

    Study coordinator · 775-982-5050
  • Atlantic Health Morristown Medical Center ( Site 0077), Morristown, New Jersey, United States

    Study coordinator · 973-971-7000
  • Cayuga Medical Center ( Site 0086), Ithaca, New York, United States

    Study coordinator · 607-277-4341
  • Stony Brook University-Cancer Center ( Site 0054), Stony Brook, New York, United States

    Study coordinator · 631-372-7212
  • White Plains Hospital ( Site 0091), White Plains, New York, United States

    Study coordinator · 914-681-0600
  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0057), Fargo, North Dakota, United States

    Study coordinator · 701-234-6161
  • Hightower Clinical, LLC ( Site 0084), Oklahoma City, Oklahoma, United States

    Study coordinator · 405-479-8331
  • Oregon Health and Science University ( Site 0052), Portland, Oregon, United States

    Study coordinator · 503-494-0283
  • Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey, Pennsylvania, United States

    Study coordinator · 717-531-0003
  • Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster, Pennsylvania, United States

    Study coordinator · 717-544-0511
  • Saint Joseph's Candler Health System ( Site 4010), Bluffton, South Carolina, United States

    Study coordinator · 912-819-5704
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston, South Carolina, United States

    Study coordinator · 843-792-4271
  • Sanford Cancer Center ( Site 0053), Sioux Falls, South Dakota, United States

    Study coordinator · 605-328-8800
  • Avera Cancer Institute- Research ( Site 0090), Sioux Falls, South Dakota, United States

    Study coordinator · 605-322-3295
  • University of Tennessee Medical Center Knoxville ( Site 0082), Knoxville, Tennessee, United States

    Study coordinator · 865-305-9000
  • Millennium Research & Clinical Development ( Site 0039), Houston, Texas, United States

  • Huntsman Cancer Institute ( Site 0042), Salt Lake City, Utah, United States

    Study coordinator · 801-587-7000
  • Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0213), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · +541149590200
  • Hospital Británico de Buenos Aires-Oncology ( Site 0207), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · +541143096400
  • Sanatorio Británico-Clinical Oncology Department ( Site 0206), Rosario, Santa Fe Province, Argentina

    Study coordinator · 5493416575134
  • Sanatorio Parque ( Site 0205), Rosario, Santa Fe Province, Argentina

    Study coordinator · 5493416955611
  • Clínica Mayo de Urgencias Médicas Cruz Blanca S.R.L ( Site 0217), San Miguel de Tucumán, Tucumán Province, Argentina

    Study coordinator · 543814752113
  • Hospital Aleman-Oncology ( Site 0202), Buenos Aires, Argentina

    Study coordinator · +541148277000
  • Hospital Privado Universitario de Córdoba-Hematology and Oncology ( Site 0204), Córdoba, Argentina

    Study coordinator · +543514688200
  • Westmead Hospital ( Site 0701), Westmead, New South Wales, Australia

    Study coordinator · 0298455200
  • The Prince Charles Hospital ( Site 0700), Brisbane, Queensland, Australia

    Study coordinator · +61736470368
  • Fiona Stanley Hospital-Medical Oncology ( Site 0705), Murdoch, Western Australia, Australia

    Study coordinator · 08 61526530
  • Medizinische Universitaet Innsbruck-Department for Internal Medicine V ( Site 1403), Innsbruck, Tyrol, Austria

    Study coordinator · 43512 50480308
  • Ordensklinikum Linz GmbH Elisabethinen-Department of Pneumology ( Site 1402), Linz, Upper Austria, Austria

    Study coordinator · 4373276764428
  • Standort Penzing der Klinik Ottakring-Abteilung für Atemwegs-und Lungenkrankheiten ( Site 1401), Vienna, Austria

    Study coordinator · 4319106042008
  • Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 1400), Vienna, Austria

    Study coordinator · 431277002237
  • Antwerp University Hospital-Thoracic Oncology ( Site 1503), Edegem, Antwerpen, Belgium

    Study coordinator · +32 3 821 56 81
  • Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi ( Site 1502), Yvoir, Namur, Belgium

    Study coordinator · 081423351
  • VITAZ ( Site 1500), Sint-Niklaas, Oost-Vlaanderen, Belgium

    Study coordinator · +32 3760 2926
  • Liga Norte Riograndense Contra o Câncer ( Site 0301), Natal, Rio Grande do Norte, Brazil

    Study coordinator · +558440095595
  • Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 0303), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · 51997292910
  • Hospital Nossa Senhora da Conceição ( Site 0302), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555133572296
  • Instituto de Oncologia Saint Gallen ( Site 0319), Santa Cruz do Sul, Rio Grande do Sul, Brazil

    Study coordinator · +55513056-8686
  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0304), Barretos, São Paulo, Brazil

    Study coordinator · +551733216638 ex6638
  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0313), São José do Rio Preto, São Paulo, Brazil

    Study coordinator · +55 1798135-0180
  • ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 0305), São Paulo, Brazil

    Study coordinator · +551138932632
  • Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0100), Greenfield Park, Quebec, Canada

    Study coordinator · 450-466-5000#3226
  • Centre Hospitalier de l'Université de Montréal ( Site 0104), Montreal, Quebec, Canada

    Study coordinator · 5148908000x26214
  • St. Marys Hospital Center ( Site 0107), Montreal, Quebec, Canada

    Study coordinator · 514-345-3511
  • McGill University Health Centre ( Site 0105), Montreal, Quebec, Canada

    Study coordinator · 5149341934X36675
  • FALP-UIDO ( Site 0401), Providencia, Region M. de Santiago, Chile

    Study coordinator · +56224205098
  • Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0404), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56991612199
  • Clínica RedSalud Vitacura ( Site 0412), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56 9 8292 6243
  • Bradfordhill-Clinical Area ( Site 0400), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56229490970
  • ONCOCENTRO APYS-ACEREY ( Site 0410), Viña del Mar, Valparaiso, Chile

    Study coordinator · +56323320850
  • Beijing Cancer hospital-Thoracic Surgery department I ( Site 1301), Beijing, Beijing Municipality, China

    Study coordinator · 86-10-88121122
  • Beijing Peking Union Medical College Hospital-Thoracic surgery department ( Site 1302), Beijing, Beijing Municipality, China

    Study coordinator · 86-10-69151188
  • Peking University People's Hospital ( Site 1300), Beijing, Beijing Municipality, China

    Study coordinator · 01088326666
  • Fujian Cancer Hospital-oncology department ( Site 1314), Fuzhou, Fujian, China

    Study coordinator · 0591-83660063
  • The First Affiliated Hospital of Guangzhou Medical University-thoracic surgery department ( Site 1320), Guangzhou, Guangdong, China

    Study coordinator · +86 13660202355
  • Southern Medical University Nanfang Hospital-Thoracic surgery department ( Site 1313), Guangzhou, Guangdong, China

    Study coordinator · 020-61641821
  • Henan Cancer Hospital-henan cancer hospital ( Site 1316), Zhengzhou, Henan, China

    Study coordinator · 0371-65588178
  • Union Hospital Tongji Medical College Huazhong University of Science and Technology-Thoracic Surgery ( Site 1306), Wuhan, Hubei, China

    Study coordinator · 027-85351615
  • Hubei Cancer Hospital ( Site 1308), Wuhan, Hubei, China

    Study coordinator · 027-87670445
  • Xiangya Hospital Central South University-Thoracic surgery ( Site 1311), Changsha, Hunan, China

    Study coordinator · 0731-89753003
  • Hunan Cancer Hospital ( Site 1312), Changsha, Hunan, China

    Study coordinator · 0731-89762112
  • Nanjing First Hospital ( Site 1310), Nanjing, Jiangsu, China

    Study coordinator · 025-52271064
  • The First Affiliated Hospital of Soochow University-Thoracic Surgery Department ( Site 1318), Suzhou, Jiangsu, China

    Study coordinator · 0512-67780040
  • The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 1330), Nanchang, Jiangxi, China

    Study coordinator · 0791-88695051
  • The First Hospital of Jilin University ( Site 1324), Changchun, Jilin, China

    Study coordinator · +86-431-81875309
  • The Second Affiliated Hospital of Air Force Medical University ( Site 1332), Xi'an, Shaanxi, China

    Study coordinator · 02984756100
  • Shandong Cancer Hospital ( Site 1321), Jinan, Shandong, China

    Study coordinator · +86-531-67626232
  • Zhongshan Hospital Fudan University ( Site 1325), Shanghai, Shanghai Municipality, China

    Study coordinator · 02131587861
  • Shanghai Pulmonary Hospital-Thoracic Surgery department ( Site 1304), Shanghai, Shanghai Municipality, China

    Study coordinator · 021-65115006
  • Sichuan Cancer hospital. ( Site 1327), Chengdu, Sichuan, China

    Study coordinator · 028-85420156
  • The Second People's Hospital of Neijiang ( Site 1322), Neijiang, Sichuan, China

  • Yunnan Province Cancer Hospital ( Site 1315), Kunming, Yunnan, China

    Study coordinator · 087168178106
  • The first Affiliated Hospital, Zhejiang University School of-Thoracic Cardiovascular Surgery Ward ( Site 1303), Hangzhou, Zhejiang, China

    Study coordinator · 0571-87236114
  • Zhejiang Cancer Hospital ( Site 1309), Hangzhou, Zhejiang, China

    Study coordinator · 0571-88128276
  • Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 1328), Hangzhou, Zhejiang, China

    Study coordinator · 0571-86006992
  • Taizhou Hospital of Zhejiang Province ( Site 1329), Linhai, Zhejiang, China

    Study coordinator · 0576-85199810
  • Ningbo No. 2 Hospital ( Site 1305), Ningbo, Zhejiang, China

    Study coordinator · 057483870375
  • Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 1600), Brno, Brno-mesto, Czechia

    Study coordinator · +420543134008
  • Nemocnice AGEL Ostrava - Vitkovice a.s.-Plicni oddeleni ( Site 1601), Ostrava, Ostrava Mesto, Czechia

    Study coordinator · +420595633400
  • CHRU de Brest ( Site 1804), Brest, Finistere, France

    Study coordinator · +33298223298
  • CHU de Toulouse - Hopital Larrey-service de pneumologie ( Site 1801), Toulouse, Haute-Garonne, France

    Study coordinator · +33567771859
  • CHU Charles Nicolle ( Site 1803), Rouen, Haute-Normandie, France

    Study coordinator · +33232888079
  • Centre Hospitalier Universitaire de Limoges - Hôpital Dupuytren ( Site 1805), Limoges, Haute-Vienne, France

    Study coordinator · 33555056892
  • Clinique Teissier Groupe ( Site 1811), Valenciennes, Nord, France

    Study coordinator · +33327142434
  • Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 1810), Clermont-Ferrand, Puy-de-Dome, France

    Study coordinator · +33473278080
  • Hospices Civils de Lyon - Hopital Louis Pradel ( Site 1809), Bron, Rhone, France

    Study coordinator · +33427855594
  • HIA Sainte Anne ( Site 1800), Toulon, Var, France

    Study coordinator · 0033483162937
  • Hôpital Tenon ( Site 1802), Paris, France

    Study coordinator · 33156016531
  • Groupe hospitalier Paris saint Joseph. ( Site 1807), Paris, Île-de-France Region, France

    Study coordinator · +33144123159
  • Klinikum Esslingen-Klinik für Kardiologie und Pneumologie ( Site 1914), Esslingen am Neckar, Baden-Wurttemberg, Germany

    Study coordinator · 71131032402
  • Universitaetsklinikum Regensburg ( Site 1907), Regensburg, Bavaria, Germany

    Study coordinator · +499419447285
  • Lungenklinik Hemer ( Site 1905), Hemer, North Rhine-Westphalia, Germany

    Study coordinator · 02372 9080
  • Katholisches Klinikum Koblenz ( Site 1911), Koblenz, Rhineland-Palatinate, Germany

    Study coordinator · 00492614964095
  • Universitätsklinikum Leipzig ( Site 1915), Leipzig, Saxony, Germany

    Study coordinator · 00493419712600
  • Krankenhaus Martha-Maria Halle-Dölau-Klinik für Innere Medizin II ( Site 1908), Halle, Saxony-Anhalt, Germany

    Study coordinator · +493455591434
  • Zentralklinik Bad Berka-Klinik für Hämatologie und Onkologie ( Site 1902), Bad Berka, Thuringia, Germany

    Study coordinator · +493645851501
  • SRH Wald-Klinikum Gera-Lungenkrebszentrum ( Site 1900), Gera, Thuringia, Germany

    Study coordinator · +493658282151
  • Evangelische Lungenklinik Berlin-Pneumologie ( Site 1904), Berlin, Germany

    Study coordinator · +4930948020
  • Charité Campus Virchow-Klinikum-Department of Infectious Diseases and Pulmonary Medicine ( Site 1903), Berlin, Germany

    Study coordinator · +4930450553412
  • Vivantes Hospital Spandau-Klinik für Innere Medizin, Hämatologie, Onkologie und Gastroenterologie- ( Site 1912), Berlin, Germany

    Study coordinator · 4930130132629
  • Helios Klinikum Emil von Behring Berlin-Zehlendorf ( Site 1916), Berlin, Germany

    Study coordinator · +493081021506
  • UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 2006), Pátrai, Achaia, Greece

    Study coordinator · +302610999791
  • 251 Hellenic Air Force General Hospital ( Site 2003), Athens, Attica, Greece

    Study coordinator · 0030 2107464642
  • THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 2000), Athens, Attica, Greece

    Study coordinator · +302107700220
  • Athens Medical Center ( Site 2005), Athens, Attica, Greece

    Study coordinator · +302106157392
  • Metaxa Cancer Hospital of Piraeus ( Site 2002), Piraeus, Attica, Greece

    Study coordinator · +302132079225
  • University General Hospital of Heraklion-Internal Medicine-Oncology ( Site 2001), Heraklion, Irakleio, Greece

    Study coordinator · 0030 2810392438
  • University General Hospital of Larissa-Oncology Clinic ( Site 2004), Larissa, Thessaly, Greece

    Study coordinator · +302413502124
  • European Interbalkan Medical Center ( Site 2007), Thessaloniki, Greece

    Study coordinator · 0030 2310400213
  • Queen Mary Hospital ( Site 3400), Hksar, Hong Kong

    Study coordinator · +852 2255 3838
  • Hong Kong United Oncology Centre ( Site 3403), Kowloon, Hong Kong

    Study coordinator · +852 2386 8002
  • Queen Elizabeth Hospital ( Site 3402), Yau Ma Tei, Hong Kong

    Study coordinator · +852 3506 8888
  • Rambam Health Care Campus-Oncology Division ( Site 2203), Haifa, Israel

    Study coordinator · +972-4-7776234
  • Shaare Zedek Medical Center ( Site 2206), Jerusalem, Israel

    Study coordinator · +97226555768
  • Rabin Medical Center ( Site 2204), Petah Tikva, Israel

    Study coordinator · +97239378086
  • Sheba Medical Center ( Site 2200), Ramat Gan, Israel

    Study coordinator · +972-35307032
  • Humanitas Istituto Clinico Catanese ( Site 2315), Misterbianco, Catania, Italy

    Study coordinator · +3909573390167
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 2302), Meldola, Emilia-Romagna, Italy

    Study coordinator · +393487469100
  • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 2300), Milan, Lombardy, Italy

    Study coordinator · +390223903829
  • San Paolo - ASST SANTI PAOLO E CARLO ( Site 2314), Milan, Lombardy, Italy

    Study coordinator · +390240222119
  • Fondazione IRCCS San Gerardo dei Tintori-Oncologia ( Site 2301), Monza, Lombardy, Italy

    Study coordinator · +390392339285
  • Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 2309), Rome, Roma, Italy

    Study coordinator · 0652665698
  • Azienda Ospedaliera Universitaria Careggi-SOD ONCOLOGIA MEDICA ( Site 2307), Florence, Tuscany, Italy

    Study coordinator · +390557947298
  • Humanitas Gavazzeni-ONCOLOGY ( Site 2310), Bergamo, Italy

    Study coordinator · +390354204106
  • Ospedale San Martino ( Site 2313), Genova, Italy

    Study coordinator · +390105558918
  • Ospedale San Raffaele-Oncologia Medica ( Site 2311), Milan, Italy

    Study coordinator · +390226434856
  • Azienda Ospedaliero Universitaria di Parma ( Site 2312), Parma, Italy

    Study coordinator · +39521702660
  • Fondazione IRCCS Policlinico San Matteo-Oncology ( Site 2303), Pavia, Italy

    Study coordinator · +390382503938
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 2306), Roma, Italy

    Study coordinator · +390630156318
  • APSS- Presidio Ospedaliero S. Chiara ( Site 2304), Trento, Italy

    Study coordinator · +390461902478
  • National Cancer Center Hospital East ( Site 1202), Kashiwa, Chiba, Japan

    Study coordinator · +81-4-7133-1111
  • National Hospital Organization Shikoku Cancer Center ( Site 1216), Matsuyama, Ehime, Japan

    Study coordinator · +81-89-999-1111
  • Hospital of the University of Occupational and Environmental Health, Japan ( Site 1217), Kitakyushu, Fukuoka, Japan

    Study coordinator · +81-93-603-1611
  • Kobe City Medical Center General Hospital ( Site 1213), Kobe, Hyōgo, Japan

    Study coordinator · +81-78-302-4321
  • St. Marianna University Hospital ( Site 1207), Kawasaki, Kanagawa, Japan

    Study coordinator · +81-44-977-8111
  • Kanagawa Cancer Center ( Site 1206), Yokohama, Kanagawa, Japan

    Study coordinator · +81-45-520-2222
  • Kansai Medical University Hospital ( Site 1211), Hirakata, Osaka, Japan

    Study coordinator · +81-72-804-0101
  • Kindai University Hospital ( Site 1212), Sakai, Osaka, Japan

    Study coordinator · +81-72-366-0221
  • Saitama Prefectural Cancer Center ( Site 1201), Kitaadachi-gun, Saitama, Japan

    Study coordinator · +81-48-722-1111
  • Juntendo University Hospital ( Site 1204), Bunkyo-ku, Tokyo, Japan

    Study coordinator · +81-3-3813-3111
  • Tokyo Medical University Hospital ( Site 1203), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3342-6111
  • National Hospital Organization Kyushu Cancer Center ( Site 1218), Fukuoka, Japan

    Study coordinator · +81-92-541-3231
  • Fukushima Medical University Hospital ( Site 1200), Fukushima, Japan

    Study coordinator · +81-24-547-1111
  • Hiroshima University Hospital ( Site 1215), Hiroshima, Japan

    Study coordinator · +81-82-257-5555
  • Nagasaki University Hospital ( Site 1220), Nagasaki, Japan

    Study coordinator · +81-95-819-7200
  • Niigata Cancer Center Hospital ( Site 1208), Niigata, Japan

    Study coordinator · +81-25-266-5111
  • Okayama University Hospital ( Site 1214), Okayama, Japan

    Study coordinator · +81-86-235-7991
  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 1210), Osaka, Japan

    Study coordinator · +81-6-6945-1181
  • Nippon Medical School Hospital ( Site 1205), Tokyo, Japan

    Study coordinator · +81-3-3822-2131
  • Yamagata University Hospital ( Site 1219), Yamagata, Japan

    Study coordinator · +81-23-633-1122
  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 0506), Guadalajara, Jalisco, Mexico

    Study coordinator · +52 33 3044 7001
  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 0508), Monterrey, Nuevo León, Mexico

    Study coordinator · 5519336943
  • Centro de Investigacion Clinica de Oaxaca ( Site 0509), Oaxaca City, Oaxaca, Mexico

    Study coordinator · 951209524
  • Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 0504), Chihuahua City, Mexico

    Study coordinator · +52 614 455 9270
  • Mediadvance Clinical ( Site 0502), Chihuahua City, Mexico

    Study coordinator · +52 614 674 0705
  • Oaxaca Site Management Organization S.C. ( Site 0507), Oaxaca City, Mexico

    Study coordinator · 529515147056
  • Amphia Ziekenhuis, locatie Breda Molengracht-long oncologie ( Site 3453), Breda, North Brabant, Netherlands

    Study coordinator · +0765955349
  • Isala, locatie Zwolle-Poli Longziekten ( Site 3454), Zwolle, Overijssel, Netherlands

    Study coordinator · +0031655804447
  • Leids Universitair Medisch Centrum-Longziekten ( Site 3451), Leiden, South Holland, Netherlands

    Study coordinator · 0715262950
  • Erasmus Medisch Centrum ( Site 3452), Rotterdam, South Holland, Netherlands

    Study coordinator · +0107030323
  • Meander Medisch Centrum-Researchbureau Longgeneeskunde ( Site 3458), Amersfoort, Utrecht, Netherlands

    Study coordinator · +31338507843
  • University Medical Center Groningen ( Site 3459), Groningen, Netherlands

    Study coordinator · 0503616161
  • Martini Ziekenhuis ( Site 3460), Groningen, Netherlands

    Study coordinator · 0505246311
  • Sint Antonius Ziekenhuis ( Site 3455), Utrecht, Netherlands

    Study coordinator · +0883201411
  • Auckland City Hospital ( Site 0800), Auckland, New Zealand

    Study coordinator · +6493074949
  • Akershus Universitetssykehus ( Site 2501), Lørenskog, Akershus, Norway

    Study coordinator · +4767960000
  • Drammen Sykehus, Vestre Viken HF ( Site 2502), Drammen, Buskerud, Norway

    Study coordinator · +4732803000
  • Sykehuset Innlandet HF Gjøvik ( Site 2503), Gjøvik, Oppland, Norway

    Study coordinator · +4791 50 62 00
  • Oslo universitetssykehus HF. Radiumhospitalet ( Site 2504), Oslo, Norway

    Study coordinator · +4722934000
  • IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 0604), Lima, Peru

    Study coordinator · +51 956 754 968
  • Oncosalud ( Site 0602), Lima, Peru

    Study coordinator · +51 988 966 244
  • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 0600), Lima, Peru

    Study coordinator · +51 957511783
  • Instituto Neuro Cardiovascular de las Americas ( Site 0607), Lima, Peru

    Study coordinator · +51 991366612
  • Hospital Nacional Edgardo Rebagliati Martins-medical oncology ( Site 0603), Lima, Peru

    Study coordinator · +51998870468
  • Wielkopolskie Centrum Pulmonologii i Torakochirurgii-Oddzial Onkologii Klinicznej z Pododdzialem Dz ( Site 2602), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48 616 654 242
  • Uniwersytecki Szpital Kliniczny nr 4 w Lublinie ( Site 2611), Lublin, Lublin Voivodeship, Poland

    Study coordinator · +48 602405127
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 2600), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · +48225463066
  • Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2601), Przemyśl, Podkarpackie Voivodeship, Poland

    Study coordinator · +48166775000
  • Bialostockie Centrum Onkologii ( Site 2604), Bialystok, Podlaskie Voivodeship, Poland

    Study coordinator · +48856646732
  • Uniwersytecki Szpital Kliniczny w Białymstoku ( Site 2612), Bialystok, Podlaskie Voivodeship, Poland

    Study coordinator · 858316522
  • Uniwersyteckie Centrum Kliniczne ( Site 2610), Gdansk, Pomeranian Voivodeship, Poland

  • Szpital Specjalistyczny w Prabutach Spolka z o.o. ( Site 2613), Prabuty, Pomeranian Voivodeship, Poland

    Study coordinator · +48 552624328
  • Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemioterapii ( Site 2606), Olsztyn, Warmian-Masurian Voivodeship, Poland

    Study coordinator · +48895322935
  • Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 2703), Lisbon, Lisbon District, Portugal

    Study coordinator · (351)217548085
  • UNIDADE LOCAL DE SAUDE DE MATOSINHOS-Serviço de Oncologia ( Site 2705), Matosinhos Municipality, Porto District, Portugal

    Study coordinator · (351) 229391233
  • Instituto Portugês de Oncologia de Coimbra Francisco Gentil-Oncologia Médica ( Site 2704), Coimbra, Portugal

    Study coordinator · (351)217229800
  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2702), Porto, Portugal

    Study coordinator · (351)225084000
  • MEMORIAL HEALTHCARE INTERNATIONAL S.R.L.. ( Site 2803), Bucharest, Bucharest, Romania

    Study coordinator · +40319393
  • Cardiomed SRL Cluj-Napoca-Medical Oncology ( Site 2801), Cluj-Napoca, Cluj, Romania

  • SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2802), Florești, Cluj, Romania

    Study coordinator · +40219368
  • Centrul de Oncologie Sfantul Nectarie-Medical ( Site 2805), Craiova, Dolj, Romania

  • Spitalul Clinic Municipal De Urgenta Timisoara ( Site 2806), Timișoara, Timiș County, Romania

    Study coordinator · +40256200048
  • SC ONCO CARD SRL ( Site 2808), Brasov, Romania

    Study coordinator · +40268960
  • SC MNT HEALTHCARE EUROPE SRL ( Site 2811), Bucharest, Romania

    Study coordinator · +40 21 9230
  • Spitalul Clinic De Urgenta Prof Dr Agrippa Ionescu ( Site 2804), Bucharest, Romania

    Study coordinator · +40213161600
  • Institutul Regional de Oncologie ( Site 2807), Iași, Romania

    Study coordinator · +40374.278.811
  • National Cancer Center-Lung Cancer Center ( Site 1002), Goyang-si, Kyonggi-do, South Korea

    Study coordinator · +82319201694
  • Seoul National University Bundang Hospital-Medical Oncology ( Site 1003), Seongnam, Kyonggi-do, South Korea

    Study coordinator · +82-31-787-7071
  • The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 1001), Suwon, Kyonggi-do, South Korea

    Study coordinator · 82-31-249-8455
  • Chungbuk National University Hospital-Internal medicine ( Site 1000), Cheongju-si, North Chungcheong, South Korea

    Study coordinator · +82-43-269-6015
  • Keimyung University Dongsan Hospital CRC room 1 ( Site 1006), Daegu, Taegu-Kwangyokshi, South Korea

    Study coordinator · +82532586671
  • Asan Medical Center-Lung Cancer Center ( Site 1005), Seoul, South Korea

    Study coordinator · +82319201694
  • Samsung Medical Center-Division of Hematology/Oncology ( Site 1004), Seoul, South Korea

    Study coordinator · 82-2-3410-3453
  • Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2901), L'Hospitalet de Llobregat, Barcelona, Spain

    Study coordinator · +34932607744
  • CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 2905), Santiago de Compostela, La Coruna, Spain

    Study coordinator · +34981950511
  • Hospital Insular de Gran Canaria-Oncology ( Site 2903), Las Palmas de Gran Canaria, Las Palmas, Spain

    Study coordinator · +34 928441738
  • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 2902), Pozuelo de Alarcón, Madrid, Spain

    Study coordinator · 34914521987
  • Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 2900), Barcelona, Spain

    Study coordinator · +34932746000
  • Hospital Clinico San Carlos-Oncology Department ( Site 2904), Madrid, Spain

    Study coordinator · 34 913303000 x484835
  • CHUV (centre hospitalier universitaire vaudois) ( Site 3003), Lausanne, Canton of Vaud, Switzerland

    Study coordinator · +41795560440
  • Kantonsspital Graubünden-Medizin ( Site 3006), Chur, Kanton Graubünden, Switzerland

    Study coordinator · +41812566646
  • Kantonsspital Münsterlingen - Spital Thurgau AG ( Site 3005), Münsterlingen, Thurgau, Switzerland

    Study coordinator · +41 58 144 1563
  • HFR Fribourg - Hôpital Cantonal ( Site 3004), Fribourg, Switzerland

    Study coordinator · +41263062015
  • National Taiwan University Cancer Center (NTUCC) ( Site 1105), Taipei City, Taipei, Taiwan

    Study coordinator · +886223123456x271659
  • Tri-Service General Hospital ( Site 1100), Taipei City, Taipei, Taiwan

    Study coordinator · +886287923311x13899
  • Taoyuan General Hospital ( Site 1106), Taoyuan City, Taoyuan, Taiwan

    Study coordinator · +88633699721x8502
  • Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 1103), Kaohsiung City, Taiwan

    Study coordinator · +88673121101
  • Taichung Veterans General Hospital-Chest ( Site 1101), Taichung, Taiwan

    Study coordinator · +886423592525x3256
  • National Cheng Kung University Hospital-Clinical Trial Center ( Site 1102), Tainan, Taiwan

  • National Taiwan University Hospital-Oncology ( Site 1104), Taipei, Taiwan

    Study coordinator · +886223123456x267511
  • Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 3106), Adana, Turkey (Türkiye)

    Study coordinator · +903223444444
  • Gulhane Egitim Arastirma Hastanesi-Onkoloji ( Site 3104), Ankara, Turkey (Türkiye)

    Study coordinator · 00903123042000
  • Hacettepe Universite Hastaneleri-oncology hospital ( Site 3101), Ankara, Turkey (Türkiye)

    Study coordinator · +90 (312) 305 50 00
  • Memorial Ankara Hastanesi-Medical Oncology ( Site 3110), Ankara, Turkey (Türkiye)

    Study coordinator · 903122536666
  • Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 3103), Ankara, Turkey (Türkiye)

    Study coordinator · +90 312 552 60 00
  • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 3107), Istanbul, Turkey (Türkiye)

    Study coordinator · +902165666614
  • Erciyes Universitesi Tıp Fakultesi Hastanesi ( Site 3111), Kayseri, Turkey (Türkiye)

    Study coordinator · 905388731881
  • Addenbrooke's Hospital ( Site 3217), Cambridge, Cambridgeshire, United Kingdom

    Study coordinator · +441223 805000
  • Mount Vernon Hospital ( Site 3218), Northwood, Hillingdon, United Kingdom

    Study coordinator · 02038262403
  • St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 3203), London, London, City of, United Kingdom

    Study coordinator · 02073777000
  • Churchill Hospital ( Site 3219), Oxford, Oxfordshire, United Kingdom

    Study coordinator · +44 (0) 300 304 7777
  • Freeman Hospital-Northern Centre for Cancer Care ( Site 3212), Newcastle upon Tyne, United Kingdom

    Study coordinator · 01912336161
Study leads
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC